• Our People
  • Global Presence
  • Regions
    • Asia
    • Europe
    • Americas
  • Offices
    • Canada
      • Ottawa
      • Toronto
    • China
      • Beijing
      • Hong Kong
    • Luxembourg
    • Malaysia
    • Singapore
    • UK
      • Aberdeen
      • Birmingham
      • Cambridge
      • Edinburgh
      • Glasgow
      • London
      • Manchester
      • Oxford
  • Client liaison
    • Japan
    • Korea
  • Expertise
  • Services
    • Patents
    • Brands & Trade Marks
    • Designs
    • Litigation & Dispute Resolution
    • Commercial IP & Contracts
    • Due Diligence
    • Freedom to Operate
    • EPO Patent Oppositions
    • European Patent Validations
    • Anti-counterfeiting
    • Open Source & Third Party Code
  • Sectors
    • Digital Transformation
      • 3D Printing
      • Artificial Intelligence
      • Blockchain
      • Data & Connectivity
      • Extended Reality
      • Industry 4.0
    • Energy & Environment
    • Life Sciences
    • Agritech
    • Medical Technologies
    • Chemistry
    • Transport
    • Entertainment & Creative Industries
    • Food & Drink
    • Fashion & Retail
    • Universities & Research Bodies
    • Start-ups & Spin-outs
      • Creating value for start-ups
      • The IP driven start-up
    • Financial Services
  • About Us
    • Working with us
    • Awards
    • Corporate & Social Responsibility
    • Diversity & Inclusion
    • Careers
  • Insights
    • Articles
    • News
    • Events
    • Resources
    • Unified Patent Court hub
    • Beyond Brexit: European trade mark hub
    • M&C Reacts
  • Contact Us
Marks & Clerk logo
Marks & Clerk logo
Contact Us
Language
English
Our People
Global Presence
Regions
  • Asia
  • Europe
  • Americas
Offices
  • Canada
    • Ottawa
    • Toronto
  • China
    • Beijing
    • Hong Kong
  • Luxembourg
  • Malaysia
  • Singapore
  • UK
    • Aberdeen
    • Birmingham
    • Cambridge
    • Edinburgh
    • Glasgow
    • London
    • Manchester
    • Oxford
Client liaison
  • Japan
  • Korea
Expertise
Services
  • Patents
  • Brands & Trade Marks
  • Designs
  • Litigation & Dispute Resolution
  • Commercial IP & Contracts
  • Due Diligence
  • Freedom to Operate
  • EPO Patent Oppositions
  • European Patent Validations
  • Anti-counterfeiting
  • Open Source & Third Party Code
Sectors
  • Digital Transformation
    • 3D Printing
    • Artificial Intelligence
    • Blockchain
    • Data & Connectivity
    • Extended Reality
    • Industry 4.0
  • Energy & Environment
  • Life Sciences
  • Agritech
  • Medical Technologies
  • Chemistry
  • Transport
  • Entertainment & Creative Industries
  • Food & Drink
  • Fashion & Retail
  • Universities & Research Bodies
  • Start-ups & Spin-outs
    • Creating value for start-ups
    • The IP driven start-up
  • Financial Services
About Us
  • Working with us
  • Awards
  • Corporate & Social Responsibility
  • Diversity & Inclusion
  • Careers
Insights
  • Articles
  • News
  • Events
  • Resources
  • Unified Patent Court hub
  • Beyond Brexit: European trade mark hub
  • M&C Reacts

Living with Covid-19

Covid-19

Managing your intellectual property

The global coronavirus epidemic is impacting individuals and businesses across the world. First and foremost this is a human tragedy, causing suffering to thousands worldwide. While different governments are taking different approaches in jurisdictions globally, the overarching aim is to contain the spread of the virus and therefore minimise casualties while also managing demand on overstretched healthcare systems. This comes with significant economic costs as whole sections of the economy are temporarily closed, leading to job losses and economic contraction.

Never before has innovation been so important. Whether it's pharmaceutical companies searching for a vaccine or medical device manufacturers switching to the production of ventilators and other crucial medical equipment, innovation will be key in meeting the challenges posed by Covid-19.

We are committed to working with our clients and our staff to support this innovation and are producing a series of articles, podcasts and other thought leadership focused on practical advice for intellectual property holders. There are many questions which our clients are asking. How to license your IP to a third party in order that extra demand for medtech can be met? How should IP be managed when revenue is under pressure? Will existing trade marks cover the production of items that a business hasn’t previously manufactured?

In this series we aim to answer these, and other questions. These questions and more are currently front and centre for many businesses, as they seek both to navigate the choppy economic waters and contribute to wider efforts to beat the coronavirus. We hope this series will be of practical value to innovators looking to meet these challenges.

If you have any specific questions you would like us to cover, or if you have any question generally about your intellectual property and coronavirus, then please contact your regular Marks & Clerk attorney, or email info@marks-clerk.com.

Procedures & Deadlines

Across the world, businesses are adapting their processes to the current situation, and intellectual property offices (IPOs) are no different.

Find out more
Article
- 11 June 2021

Financial support for the UK creative sector welcomed by Marks & Clerk

As part of the Innovate UK Covid Support Fund, UK registered micro and small businesses in the creative sector can apply for a package of support to help grow their business.
Read more
Article
- 02 June 2020

Making the best of a bad situation – Canadian trademark trends in a time of change

Businesses in Canada and most of the rest of the world face uncertainty as the Covid-19 pandemic has forced consumers inside and businesses to change their models or close their doors, either temporarily or for good.
Read more
Article
- 11 May 2021

US announces support for waiver of intellectual property rights

In an unexpected move last week, the Office of the United States Trade Representative (on behalf of the Biden-Harris Administration) announced its support for a waiver of intellectual property protections afforded by the TRIPS Agreement for COVID-19 vaccines.
Read more
Article
- 20 November 2020

Interview: How ReagentGenie switched to rolling out a Coronavirus test distribution network

Numerous companies had to adjust rapidly and dramatically to meet the threat posed by Covid-19. In this interview, CEO Colm Ryan tells Alicia Gailliez of One Nucleus how ReagentGenie switched from selling research only test kits to rolling out a Coronavirus test distribution network in double quick time.
Read more
Article
- 05 June 2020

FBCC 'podinar': Protecting your brand during the lockdown

In this podinar, Marks & Clerk's Simon Portman and Michael Barrett, and Emma Jalonen of the Finnish-British Chamber of Commerce discuss success stories, challenges and what businesses should be considering as part of their adaptation to the “new normal”.
Read more
Article
- 28 May 2020

Webinar: Implications of Covid-19 on the future of IP, insurance & cybersecurity

The current COVID-19 crisis presents both challenges and opportunities to the immersive tech community. Remote working, collaboration and communication are physically safer but what about the cyber security risks?
Read more

Stay informed

IP insights direct to your inbox

Subscribe
Marks & Clerk logo (white)
  • Terms & Conditions
  • Privacy Notice
  • Cookies
  • Legal Notices
  • Press Enquiries
  • Lexology
  • Mondaq